PMID: 9543346Jun 6, 1998Paper

Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats

Molecular and Cellular Biochemistry
M L BattellJ H McNeill

Abstract

Sodium selenate, administered intraperitoneally (i.p.), resulted in an improvement in glucose tolerance in treated diabetic rats. Fed rat plasma glucose levels were reduced by selenate treatment in streptozotocin diabetic rats. The lowest values of blood glucose were reached within 3 weeks of beginning the treatment. Food and fluid consumption was reduced in treated compared to untreated diabetic rats. Diabetic treated rats did not release insulin in response to a glucose challenge and insulin release in response to a challenge was markedly reduced in control treated rats. Assessment of heart function using a working heart apparatus showed that treated diabetic rats with improved blood glucose levels had normal heart function at 8 weeks of diabetes in contrast to hearts from non-treated diabetics. This study extends previous observations on the in vivo insulin-like effects of sodium selenate.

Citations

Oct 6, 2007·Biological Trace Element Research·Zubeyde ErbayraktarCanan Coker
Nov 17, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Mikiya FujiedaHideaki Enza
Dec 24, 2009·Canadian Journal of Physiology and Pharmacology·Esma N Zeydanli, Belma Turan
Sep 10, 2009·Free Radical Research·Andreas S MuellerJosef Pallauf
Jul 25, 2009·The Biochemical Journal·Frederick P BellingerMarla J Berry
May 16, 2015·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Z OztürkA Var
May 18, 2005·Canadian Journal of Physiology and Pharmacology·Prabhakara Reddy NagareddyJohn H McNeill
Feb 11, 2003·Journal of Cellular Biochemistry·Emma Heart, Chin K Sung
Mar 4, 2005·Treatments in Endocrinology·Dominique Bonnefont-Rousselot
Mar 25, 2005·Journal of Animal Physiology and Animal Nutrition·A S MüllerJ Pallauf
Jun 29, 2010·Antioxidants & Redox Signaling·Matthew P PepperXin Gen Lei
May 8, 2004·Archives of Biochemistry and Biophysics·Murat AyazBelma Turan
May 28, 2004·Toxicology and Applied Pharmacology·Chin-Hsiao Tseng
Apr 23, 2005·Toxicology and Applied Pharmacology·Christy C Bridges, Rudolfs K Zalups
Jun 29, 2021·Journal of Diabetes and Metabolic Disorders·Samira BoussekineHamza Gattel
Jun 22, 2005·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Xi-Qun ShengHui-Bi Xu
Sep 30, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Marco RomanCarlo Barbante

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.